Nuveen Asset Management’s Albireo Pharma, Inc. Common Stock ALBO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-40,260
| Closed | -$870K | – | 3161 |
|
|
2022
Q4 | $870K | Sell |
40,260
-52,803
| -57% | -$1.14M | ﹤0.01% | 2737 |
|
|
2022
Q3 | $1.8M | Buy |
93,063
+55,774
| +150% | +$1.08M | ﹤0.01% | 2448 |
|
|
2022
Q2 | $741K | Sell |
37,289
-11,518
| -24% | -$229K | ﹤0.01% | 2909 |
|
|
2022
Q1 | $1.41M | Sell |
48,807
-4,130
| -8% | -$119K | ﹤0.01% | 2674 |
|
|
2021
Q4 | $1.09M | Sell |
52,937
-3,694
| -7% | -$76.1K | ﹤0.01% | 2833 |
|
|
2021
Q3 | $1.74M | Buy |
56,631
+473
| +0.8% | +$14.6K | ﹤0.01% | 2734 |
|
|
2021
Q2 | $1.98M | Sell |
56,158
-3,775
| -6% | -$133K | ﹤0.01% | 2717 |
|
|
2021
Q1 | $2.11M | Sell |
59,933
-88,239
| -60% | -$3.11M | ﹤0.01% | 2585 |
|
|
2020
Q4 | $5.56M | Buy |
148,172
+73,796
| +99% | +$2.77M | ﹤0.01% | 2017 |
|
|
2020
Q3 | $2.48M | Buy |
74,376
+10,927
| +17% | +$365K | ﹤0.01% | 2277 |
|
|
2020
Q2 | $1.68M | Buy |
63,449
+12,030
| +23% | +$319K | ﹤0.01% | 2412 |
|
|
2020
Q1 | $842K | Buy |
51,419
+12,952
| +34% | +$212K | ﹤0.01% | 2583 |
|
|
2019
Q4 | $978K | Sell |
38,467
-446
| -1% | -$11.3K | ﹤0.01% | 2696 |
|
|
2019
Q3 | $779K | Buy |
38,913
+1,464
| +4% | +$29.3K | ﹤0.01% | 2796 |
|
|
2019
Q2 | $1.21M | Buy |
+37,449
| New | +$1.21M | ﹤0.01% | 2655 |
|